These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 17394085)
1. Offers of hepatitis C care do not lead to treatment. Schackman BR; Teixeira PA; Beeder AB J Urban Health; 2007 May; 84(3):455-8. PubMed ID: 17394085 [TBL] [Abstract][Full Text] [Related]
2. Effects of a brief educational program on knowledge and willingness to accept treatment among patients with hepatitis C at inner-city hospitals. Gupta K; Romney D; Briggs M; Benker K J Community Health; 2007 Aug; 32(4):221-30. PubMed ID: 17696047 [TBL] [Abstract][Full Text] [Related]
3. Racial and ethnic differences in drug treatment entry of injection drug users in Massachusetts. Lundgren LM; Amodeo M; Ferguson F; Davis K J Subst Abuse Treat; 2001 Oct; 21(3):145-53. PubMed ID: 11728788 [TBL] [Abstract][Full Text] [Related]
4. Assessing Racial Disparities in HCV Infection and Care Outcomes in a Southern Urban Population. McGonigle K; Carley T; Hoff C J Racial Ethn Health Disparities; 2018 Oct; 5(5):1052-1058. PubMed ID: 29288470 [TBL] [Abstract][Full Text] [Related]
5. Promoting equitable access to hepatitis C treatment for Indo-Chinese injecting drug users. Coupland H; Day C; Levy MT; Maher L Health Promot J Austr; 2009 Dec; 20(3):234-40. PubMed ID: 19951245 [TBL] [Abstract][Full Text] [Related]
6. Perceptions of drug users regarding hepatitis C screening and care: a qualitative study. Jordan AE; Masson CL; Mateu-Gelabert P; McKnight C; Pepper N; Bouche K; Guzman L; Kletter E; Seewald RM; Des-Jarlais DC; Sorensen JL; Perlman DC Harm Reduct J; 2013 Jun; 10():10. PubMed ID: 23786800 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C infection among men who have sex with men living with HIV in New York City, 2000-2015. Gabai CM; Moore MS; Penrose K; Braunstein S; Bocour A; Neaigus A; Winters A Sex Transm Infect; 2020 Sep; 96(6):445-450. PubMed ID: 31801894 [TBL] [Abstract][Full Text] [Related]
8. The Hepatitis C Awareness Through to Treatment (HepCATT) study: improving the cascade of care for hepatitis C virus-infected people who inject drugs in England. Harrison GI; Murray K; Gore R; Lee P; Sreedharan A; Richardson P; Hughes AJ; Wiselka M; Gelson W; Unitt E; Ratcliff K; Orton A; Trinder K; Simpson C; Ryder SD; Oelbaum S; Foster GR; Christian A; Smith S; Thomson BJ; Reynolds R; Harris M; Hickman M; Irving WL Addiction; 2019 Jun; 114(6):1113-1122. PubMed ID: 30694582 [TBL] [Abstract][Full Text] [Related]
9. Parental status of women injection drug users and entry to methadone maintenance. Lundgren LM; Schilling RF; Fitzgerald T; Davis K; Amodeo M Subst Use Misuse; 2003 Jun; 38(8):1109-31. PubMed ID: 12901451 [TBL] [Abstract][Full Text] [Related]
10. Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders. Appel PW; Ellison AA; Jansky HK; Oldak R Am J Drug Alcohol Abuse; 2004; 30(1):129-53. PubMed ID: 15083558 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C cascade of care among people who inject drugs in Vancouver, Canada. Young S; Wood E; Milloy MJ; DeBeck K; Dobrer S; Nosova E; Kerr T; Hayashi PhD K Subst Abus; 2018; 39(4):461-468. PubMed ID: 29949450 [TBL] [Abstract][Full Text] [Related]
12. A multidimensional education program at substance dependence treatment centers improves patient knowledge and hepatitis C care. Marinho RT; Costa A; Pires T; Raposo H; Vasconcelos C; Polónia C; Borges J; Soares M; Vilar G; Nogueira AM; BMC Infect Dis; 2016 Oct; 16(1):565. PubMed ID: 27733137 [TBL] [Abstract][Full Text] [Related]
13. HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations. Backus LI; Boothroyd D; Deyton LR AIDS; 2005 Oct; 19 Suppl 3():S13-9. PubMed ID: 16251809 [TBL] [Abstract][Full Text] [Related]
14. Managing chronic hepatitis C acquired through intravenous drug use. Jowett SL; Agarwal K; Smith BC; Craig W; Hewett M; Bassendine DR; Gilvarry E; Burt AD; Bassendine MF QJM; 2001 Mar; 94(3):153-8. PubMed ID: 11259690 [TBL] [Abstract][Full Text] [Related]
15. Health care utilization and risk behaviors among HIV positive minority drug users. Kang SY; Goldstein MF; Deren S J Health Care Poor Underserved; 2006 May; 17(2):265-75. PubMed ID: 16702714 [TBL] [Abstract][Full Text] [Related]
16. Health disparities among African-American and Hispanic drug injectors--HIV, AIDS, hepatitis B virus and hepatitis C virus: a review. Estrada AL AIDS; 2005 Oct; 19 Suppl 3():S47-52. PubMed ID: 16251828 [TBL] [Abstract][Full Text] [Related]
17. HCV and HBV testing acceptability and knowledge among urban emergency department patients and pharmacy clients. Calderon Y; Cowan E; Schramm C; Stern S; Brusalis C; Iscoe M; Rahman S; Verma R; Leider J Prev Med; 2014 Apr; 61():29-33. PubMed ID: 24382298 [TBL] [Abstract][Full Text] [Related]
18. Enhanced chronic hepatitis C surveillance in New York City, April 2009-January 2011. Drezner K; Bornschlegel K; McGibbon E; Balter S Public Health Rep; 2013; 128(6):510-8. PubMed ID: 24179262 [TBL] [Abstract][Full Text] [Related]
19. Limited uptake of hepatitis C treatment among injection drug users. Mehta SH; Genberg BL; Astemborski J; Kavasery R; Kirk GD; Vlahov D; Strathdee SA; Thomas DL J Community Health; 2008 Jun; 33(3):126-33. PubMed ID: 18165889 [TBL] [Abstract][Full Text] [Related]
20. Barriers to Treatment Among New York City Residents with Chronic Hepatitis C Virus Infection, 2014. King A; Bornschlegel K; Johnson N; Rude E; Laraque F Public Health Rep; 2016; 131(3):430-7. PubMed ID: 27252563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]